T1	Date 3 20	December 28, 2014
E1	Date:T1 
T2	Age 24 35	70-year-old
T3	Sex 36 39	man
T4	Sign_symptom 65 69	pain
E2	Sign_symptom:T4 
T5	Biological_structure 55 64	abdominal
R1	MODIFY Arg1:T5 Arg2:E2	
T6	Sign_symptom 71 80	dizziness
E3	Sign_symptom:T6 
T7	Sign_symptom 86 92	nausea
E4	Sign_symptom:T7 
T8	Nonbiological_location 113 149	Hebei General Hospital, Hebei, China
T9	Diagnostic_procedure 151 162	Gastroscopy
E5	Diagnostic_procedure:T9 
T10	Disease_disorder 192 210	ulcerative lesions
E6	Disease_disorder:T10 
T11	Shape 170 179	irregular
T12	Detailed_description 180 191	hemorrhagic
R2	MODIFY Arg1:T12 Arg2:E6	
R3	MODIFY Arg1:T11 Arg2:E6	
T13	Biological_structure 230 242	gastric body
T14	Biological_structure 250 266	lesser curvature
R4	MODIFY Arg1:T13 Arg2:E6	
R5	MODIFY Arg1:T14 Arg2:E6	
T15	Disease_disorder 271 287	pyloric stenosis
E7	Disease_disorder:T15 
T16	Biological_structure 295 302	stomach
R6	MODIFY Arg1:T16 Arg2:E7	
T17	Diagnostic_procedure 312 318	biopsy
E8	Diagnostic_procedure:T17 
T18	Biological_structure 304 311	Gastric
R7	MODIFY Arg1:T18 Arg2:E8	
T19	Disease_disorder 328 342	adenocarcinoma
E9	Disease_disorder:T19 
T20	Date 347 362	January 7, 2015
E10	Date:T20 
T21	Therapeutic_procedure 375 386	gastrectomy
E11	Therapeutic_procedure:T21 
T22	Detailed_description 364 374	palliative
R8	MODIFY Arg1:T22 Arg2:E11	
T23	Therapeutic_procedure 392 401	Roux-en-Y
E12	Therapeutic_procedure:T23 
T24	Therapeutic_procedure 407 426	esophagojejunostomy
E13	Therapeutic_procedure:T24 
R9	MODIFY Arg1:E12 Arg2:E13	
T25	Biological_structure 494 516	pancreatic lymph nodes
T26	Biological_structure 476 484	anterior
T27	Biological_structure 485 493	superior
T28	Biological_structure 460 471	para-aortic
R10	MODIFY Arg1:T27 Arg2:T25	
R11	MODIFY Arg1:T26 Arg2:T25	
R12	MODIFY Arg1:T28 Arg2:T25	
T29	Therapeutic_procedure 588 596	resected
E14	Therapeutic_procedure:T29 
A1	POLARITY E14 NEG
R13	MODIFY Arg1:T25 Arg2:E14	
T30	Biological_structure 529 540	lymph nodes
T31	Qualitative_concept 443 450	Diffuse
T32	Qualitative_concept 451 459	enlarged
R14	MODIFY Arg1:T32 Arg2:T25	
R15	MODIFY Arg1:T31 Arg2:T25	
T33	Biological_structure 552 573	common hepatic artery
R16	MODIFY Arg1:T33 Arg2:T30	
R17	MODIFY Arg1:T30 Arg2:E14	
T34	Diagnostic_procedure 612 621	pathology
E15	Diagnostic_procedure:T34 
T35	Disease_disorder 661 683	gastric adenocarcinoma
E16	Disease_disorder:T35 
T36	Severity 635 660	moderately differentiated
R18	MODIFY Arg1:T36 Arg2:E16	
T37	Diagnostic_procedure 694 714	Immunohistochemistry
E17	Diagnostic_procedure:T37 
T38	Diagnostic_procedure 737 777	human epidermal growth factor receptor 2
E18	Diagnostic_procedure:T38 
T39	Diagnostic_procedure 779 784	HER-2
E19	Diagnostic_procedure:T39 
R19	IDENTICAL Arg1:E19 Arg2:E18	
R20	SUB_PROCEDURE Arg1:E18 Arg2:E17	
T40	Lab_value 787 788	+
E20	Lab_value:T40 
R21	MODIFY Arg1:E20 Arg2:E18	
T41	Diagnostic_procedure 791 825	vascular endothelial growth factor
E21	Diagnostic_procedure:T41 
T42	Diagnostic_procedure 827 831	VEGF
E22	Diagnostic_procedure:T42 
T43	Lab_value 834 835	+
E23	Lab_value:T43 
R22	BEFORE Arg1:E23 Arg2:E21	
R23	IDENTICAL Arg1:E22 Arg2:E21	
R24	SUB_PROCEDURE Arg1:E21 Arg2:E17	
T44	Diagnostic_procedure 838 842	CD31
E24	Diagnostic_procedure:T44 
T45	Lab_value 844 845	+
E25	Lab_value:T45 
T46	Diagnostic_procedure 848 853	CD105
E26	Diagnostic_procedure:T46 
T47	Lab_value 855 856	+
E27	Lab_value:T47 
R25	MODIFY Arg1:E27 Arg2:E26	
R26	SUB_PROCEDURE Arg1:E26 Arg2:E17	
R27	MODIFY Arg1:E25 Arg2:E24	
R28	SUB_PROCEDURE Arg1:E24 Arg2:E17	
T48	Diagnostic_procedure 870 885	triple positive
E28	Diagnostic_procedure:T48 
T49	Diagnostic_procedure 887 889	TP
E29	Diagnostic_procedure:T49 
T50	Lab_value 892 893	+
E30	Lab_value:T50 
R29	IDENTICAL Arg1:E29 Arg2:E28	
R30	MODIFY Arg1:E30 Arg2:E28	
R31	SUB_PROCEDURE Arg1:E28 Arg2:E17	
T51	Diagnostic_procedure 896 923	glutathione S-transferase π
E31	Diagnostic_procedure:T51 
T52	Diagnostic_procedure 925 930	GST-π
E32	Diagnostic_procedure:T52 
T53	Lab_value 933 936	+++
E33	Lab_value:T53 
R32	MODIFY Arg1:E33 Arg2:E31	
R33	IDENTICAL Arg1:E32 Arg2:E31	
R34	SUB_PROCEDURE Arg1:E31 Arg2:E17	
T54	Diagnostic_procedure 939 964	topoisomerase enzyme II α
E34	Diagnostic_procedure:T54 
T55	Diagnostic_procedure 966 974	TOPOII α
E35	Diagnostic_procedure:T55 
R35	IDENTICAL Arg1:E35 Arg2:E34	
T56	Diagnostic_procedure 977 980	P53
E36	Diagnostic_procedure:T56 
T57	Lab_value 982 983	–
E37	Lab_value:T57 
T58	Diagnostic_procedure 990 995	Ki-67
E38	Diagnostic_procedure:T58 
T59	Lab_value 997 1000	70%
E39	Lab_value:T59 
R36	MODIFY Arg1:E37 Arg2:E36	
R37	MODIFY Arg1:E39 Arg2:E38	
R38	SUB_PROCEDURE Arg1:E34 Arg2:E17	
R39	SUB_PROCEDURE Arg1:E36 Arg2:E17	
R40	SUB_PROCEDURE Arg1:E38 Arg2:E17	
T60	Disease_disorder 1030 1052	gastric adenocarcinoma
E40	Disease_disorder:T60 
T61	Severity 1021 1029	stage IV
R41	MODIFY Arg1:T61 Arg2:E40	
T62	Qualitative_concept 1058 1066	multiple
T63	Biological_structure 1067 1077	lymphnodes
T64	Disease_disorder 1078 1088	metastases
E41	Disease_disorder:T64 
T65	Severity 1090 1096	T4N2M1
R42	MODIFY Arg1:T65 Arg2:E40	
R43	MODIFY Arg1:T63 Arg2:E41	
R44	MODIFY Arg1:T62 Arg2:E41	
T66	Therapeutic_procedure 1130 1151	cycle of chemotherapy
E42	Therapeutic_procedure:T66 
T67	Dosage 1128 1129	1
R45	MODIFY Arg1:T67 Arg2:E42	
T68	Medication 1157 1168	oxaliplatin
E43	Medication:T68 
T69	Medication 1173 1176	S-1
E44	Medication:T69 
R46	MODIFY Arg1:E43 Arg2:E42	
R47	MODIFY Arg1:E44 Arg2:E42	
T70	Sign_symptom 1266 1295	gastrointestinal disturbances
E45	Sign_symptom:T70 
T71	Detailed_description 1205 1215	terminated
R48	MODIFY Arg1:E45 Arg2:T71	
R49	MODIFY Arg1:T71 Arg2:E42	
T72	Date 1300 1316	February 2, 2015
E46	Date:T72 
T73	Therapeutic_procedure 1318 1339	adjuvant radiotherapy
E47	Therapeutic_procedure:T73 
T74	Diagnostic_procedure 1379 1427	positron-emission tomography computed tomography
E48	Diagnostic_procedure:T74 
T75	Diagnostic_procedure 1429 1435	PET-CT
E49	Diagnostic_procedure:T75 
R50	IDENTICAL Arg1:E49 Arg2:E48	
T76	Severity 1444 1453	extensive
T77	Detailed_description 1454 1461	distant
T78	Disease_disorder 1462 1472	metastasis
E50	Disease_disorder:T78 
R51	MODIFY Arg1:T77 Arg2:E50	
R52	MODIFY Arg1:T76 Arg2:E50	
T79	Biological_structure 1511 1522	lymph nodes
T80	Biological_structure 1474 1494	left supraclavicular
T81	Biological_structure 1499 1510	mediastinal
R53	MODIFY Arg1:T81 Arg2:T79	
R54	MODIFY Arg1:T80 Arg2:T79	
T82	Biological_structure 1528 1539	lymph nodes
T83	Biological_structure 1555 1571	abdominal cavity
R55	MODIFY Arg1:T83 Arg2:T82	
R56	MODIFY Arg1:T79 Arg2:E50	
R57	MODIFY Arg1:T82 Arg2:E50	
T84	Diagnostic_procedure 1588 1622	Eastern Cooperative Oncology Group
E51	Diagnostic_procedure:T84 
T85	Diagnostic_procedure 1624 1628	ECOG
E52	Diagnostic_procedure:T85 
R58	IDENTICAL Arg1:E52 Arg2:E51	
T86	Lab_value 1653 1654	2
E53	Lab_value:T86 
R59	MODIFY Arg1:E53 Arg2:E51	
T87	Diagnostic_procedure 1664 1679	body mass index
E54	Diagnostic_procedure:T87 
T88	Diagnostic_procedure 1681 1684	BMI
E55	Diagnostic_procedure:T88 
R60	IDENTICAL Arg1:E55 Arg2:E54	
T89	Lab_value 1690 1692	19
E56	Lab_value:T89 
R61	MODIFY Arg1:E56 Arg2:E54	
T90	Sign_symptom 1740 1752	malnutrition
E57	Sign_symptom:T90 
A2	POLARITY E57 UNCERTAIN
T91	Administration 1754 1758	Oral
T92	Medication 1759 1767	apatinib
E58	Medication:T92 
T93	Dosage 1768 1774	850 mg
T94	Frequency 1775 1785	once a day
T95	Therapeutic_procedure 1814 1826	radiotherapy
E59	Therapeutic_procedure:T95 
R62	MODIFY Arg1:T91 Arg2:E58	
R63	MODIFY Arg1:T93 Arg2:E58	
R64	MODIFY Arg1:T94 Arg2:E58	
T96	Therapeutic_procedure 1970 2007	intensity modulated radiation therapy
E60	Therapeutic_procedure:T96 
T97	Therapeutic_procedure 2009 2013	IMRT
E61	Therapeutic_procedure:T97 
R65	IDENTICAL Arg1:E61 Arg2:E60	
T98	Detailed_description 1959 1969	palliative
R66	MODIFY Arg1:T98 Arg2:E60	
T99	Clinical_event 1831 1841	prescribed
E62	Clinical_event:T99 
R67	MODIFY Arg1:E58 Arg2:E62	
R68	MODIFY Arg1:E59 Arg2:E62	
T100	Dosage 2056 2077	64 Gy in 30 fractions
T101	Biological_structure 2085 2096	mediastinum
T102	Dosage 2110 2131	52 Gy in 26 fractions
T103	Disease_disorder 2155 2173	metastatic lesions
E63	Disease_disorder:T103 
T104	Biological_structure 2145 2154	abdominal
R69	MODIFY Arg1:T104 Arg2:E63	
R70	MODIFY Arg1:T100 Arg2:T101	
R71	MODIFY Arg1:T102 Arg2:T104	
T105	Biological_structure 2208 2218	lymph node
T106	Biological_structure 2187 2207	left supraclavicular
R72	MODIFY Arg1:T106 Arg2:T105	
T107	Medication 2236 2244	apatinib
E64	Medication:T107 
R73	MODIFY Arg1:E64 Arg2:T105	
R74	MODIFY Arg1:E60 Arg2:T100	
R75	MODIFY Arg1:E60 Arg2:T102	
T108	Diagnostic_procedure 2272 2278	PET-CT
E65	Diagnostic_procedure:T108 
T109	Date 2294 2320	2 weeks after radiotherapy
E66	Date:T109 
T110	Lab_value 2331 2344	80% reduction
E67	Lab_value:T110 
T111	Diagnostic_procedure 2352 2385	maximum standardized uptake value
E68	Diagnostic_procedure:T111 
T112	Diagnostic_procedure 2387 2393	SUVmax
E69	Diagnostic_procedure:T112 
R76	IDENTICAL Arg1:E69 Arg2:E68	
T113	Diagnostic_procedure 2398 2431	2-deoxy-2-[[18]F]fluoro-d-glucose
E70	Diagnostic_procedure:T113 
T114	Diagnostic_procedure 2433 2436	FDG
E71	Diagnostic_procedure:T114 
R77	IDENTICAL Arg1:E71 Arg2:E70	
R78	MODIFY Arg1:E70 Arg2:E68	
R79	MODIFY Arg1:E67 Arg2:E68	
T115	Diagnostic_procedure 2439 2449	FDG uptake
E72	Diagnostic_procedure:T115 
T116	Lab_value 2454 2460	higher
E73	Lab_value:T116 
T117	Biological_structure 2489 2499	lymph node
T118	Biological_structure 2468 2488	left supraclavicular
R80	MODIFY Arg1:T118 Arg2:T117	
R81	MODIFY Arg1:E73 Arg2:E72	
R82	MODIFY Arg1:T117 Arg2:E72	
T119	Biological_structure 2516 2534	metastatic regions
T120	Medication 2559 2567	apatinib
E74	Medication:T120 
T121	Therapeutic_procedure 2572 2589	radiation therapy
E75	Therapeutic_procedure:T121 
T122	Diagnostic_procedure 2604 2648	Response Evaluation Criteria in Solid Tumors
E76	Diagnostic_procedure:T122 
R83	MODIFY Arg1:E74 Arg2:T119	
R84	MODIFY Arg1:E75 Arg2:T119	
T123	Diagnostic_procedure 2650 2656	RECIST
E77	Diagnostic_procedure:T123 
R85	IDENTICAL Arg1:E77 Arg2:E76	
T124	Lab_value 2683 2699	partial response
E78	Lab_value:T124 
R86	MODIFY Arg1:E78 Arg2:E76	
T125	Therapeutic_procedure 2738 2750	radiotherapy
E79	Therapeutic_procedure:T125 
T126	Dosage 2752 2773	66 Gy in 28 fractions
R87	MODIFY Arg1:T126 Arg2:E79	
T127	Biological_structure 2803 2813	lymph node
T128	Biological_structure 2782 2802	left supraclavicular
R88	MODIFY Arg1:T128 Arg2:T127	
T129	Disease_disorder 2821 2840	residual metastasis
E80	Disease_disorder:T129 
R89	CAUSE Arg1:E80 Arg2:E79	
R90	MODIFY Arg1:T127 Arg2:E79	
T130	Diagnostic_procedure 2842 2855	Tumor markers
E81	Diagnostic_procedure:T130 
T131	Diagnostic_procedure 2860 2880	biochemical analyses
E82	Diagnostic_procedure:T131 
T132	Frequency 2896 2910	every 2 months
R91	MODIFY Arg1:T132 Arg2:E82	
R92	MODIFY Arg1:T132 Arg2:E81	
T133	Date 2912 2936	Two months after therapy
E83	Date:T133 
T134	Diagnostic_procedure 2959 2967	CT scans
E84	Diagnostic_procedure:T134 
T135	Biological_structure 2938 2943	chest
T136	Biological_structure 2949 2958	abdominal
R93	MODIFY Arg1:T136 Arg2:E84	
R94	MODIFY Arg1:T135 Arg2:E84	
T137	Disease_disorder 2985 2992	disease
E85	Disease_disorder:T137 
T138	Detailed_description 2978 2984	stable
R95	MODIFY Arg1:T138 Arg2:E85	
T139	Sign_symptom 2994 3000	anemia
E86	Sign_symptom:T139 
T140	Sign_symptom 3005 3030	gastrointestinal symptoms
E87	Sign_symptom:T140 
T141	Qualitative_concept 3035 3043	improved
R96	MODIFY Arg1:T141 Arg2:E87	
R97	MODIFY Arg1:T141 Arg2:E86	
T142	Diagnostic_procedure 3045 3049	ECOG
E88	Diagnostic_procedure:T142 
T143	Diagnostic_procedure 3080 3083	BMI
E89	Diagnostic_procedure:T143 
T144	Lab_value 3073 3074	0
E90	Lab_value:T144 
T145	Lab_value 3088 3090	22
E91	Lab_value:T145 
R98	MODIFY Arg1:E90 Arg2:E88	
R99	MODIFY Arg1:E91 Arg2:E89	
T146	Sign_symptom 3092 3112	Hematologic toxicity
E92	Sign_symptom:T146 
A3	POLARITY E92 NEG
T147	Sign_symptom 3114 3126	hypertension
E93	Sign_symptom:T147 
A4	POLARITY E93 NEG
T148	Sign_symptom 3128 3145	renal dysfunction
E94	Sign_symptom:T148 
A5	POLARITY E94 NEG
T149	Sign_symptom 3147 3158	proteinuria
E95	Sign_symptom:T149 
A6	POLARITY E95 NEG
T150	Sign_symptom 3164 3182	hand–foot syndrome
E96	Sign_symptom:T150 
A7	POLARITY E96 NEG
T151	Medication 3208 3216	apatinib
E97	Medication:T151 
T152	Date 3229 3243	September 2015
E98	Date:T152 
T153	Diagnostic_procedure 3247 3268	follow-up examination
E99	Diagnostic_procedure:T153 
T154	Lab_value 3276 3285	increased
E100	Lab_value:T154 
T155	Diagnostic_procedure 3286 3315	carbohydrate antigen (CA) 125
E101	Diagnostic_procedure:T155 
T156	Diagnostic_procedure 3320 3328	ferritin
E102	Diagnostic_procedure:T156 
T157	Diagnostic_procedure 3339 3350	gastroscopy
E103	Diagnostic_procedure:T157 
T158	Diagnostic_procedure 3365 3367	CT
E104	Diagnostic_procedure:T158 
T159	Biological_structure 3355 3364	abdominal
R100	MODIFY Arg1:E100 Arg2:E101	
R101	MODIFY Arg1:E100 Arg2:E102	
R102	MODIFY Arg1:T159 Arg2:E104	
T160	Sign_symptom 3380 3393	abnormalities
E105	Sign_symptom:T160 
A8	POLARITY E105 NEG
R103	MODIFY Arg1:E105 Arg2:E104	
R104	MODIFY Arg1:E105 Arg2:E103	
T161	Date 3398 3411	November 2015
E106	Date:T161 
T162	Sign_symptom 3429 3450	difficulty swallowing
E107	Sign_symptom:T162 
T163	Sign_symptom 3480 3492	hematochezia
E108	Sign_symptom:T163 
T164	Detailed_description 3467 3479	intermittent
R105	MODIFY Arg1:T164 Arg2:E108	
T165	Diagnostic_procedure 3552 3563	Gastroscopy
E109	Diagnostic_procedure:T165 
T166	Medication 3494 3502	Apatinib
E110	Medication:T166 
T167	Sign_symptom 3525 3550	gastrointestinal bleeding
E111	Sign_symptom:T167 
T168	Detailed_description 3507 3517	terminated
R106	MODIFY Arg1:T168 Arg2:E110	
R107	CAUSE Arg1:E111 Arg2:T168	
T169	Sign_symptom 3573 3593	anastomotic stenosis
E112	Sign_symptom:T169 
T170	Disease_disorder 3601 3615	gastric cancer
E113	Disease_disorder:T170 
T171	Disease_disorder 3620 3642	intragastric hemorrhag
E114	Disease_disorder:T171 
R108	CAUSE Arg1:E113 Arg2:E112	
R109	CAUSE Arg1:E114 Arg2:E112	
T172	Therapeutic_procedure 3691 3708	chemoradiotherapy
E115	Therapeutic_procedure:T172 
A9	POLARITY E115 NEG
T173	Medication 3739 3754	hemostatic drug
E116	Medication:T173 
T174	Therapeutic_procedure 3764 3779	supportive care
E117	Therapeutic_procedure:T174 
T175	Date 3797 3809	After 1 week
E118	Date:T175 
T176	Disease_disorder 3822 3834	hemorrhaging
E119	Disease_disorder:T176 
A10	POLARITY E119 NEG
T177	Date 3849 3865	One month later,
E120	Date:T177 
T178	Detailed_description 3896 3908	intermittent
T179	Sign_symptom 3909 3921	hematochezia
E121	Sign_symptom:T179 
R110	MODIFY Arg1:T178 Arg2:E121	
T180	Date 3926 3943	December 20, 2015
E122	Date:T180 
T181	Diagnostic_procedure 3945 3951	PET-CT
E123	Diagnostic_procedure:T181 
T182	Disease_disorder 3975 3985	metastasis
E124	Disease_disorder:T182 
T183	Severity 3965 3974	extensive
R111	MODIFY Arg1:T183 Arg2:E124	
T184	Therapeutic_procedure 4029 4044	supportive care
E125	Therapeutic_procedure:T184 
T185	Date 4049 4063	April 16, 2016
E126	Date:T185 
T186	Outcome 4077 4081	died
E127	Outcome:T186 
T187	Disease_disorder 4099 4108	infection
E128	Disease_disorder:T187 
T188	Biological_structure 4089 4098	pulmonary
R112	MODIFY Arg1:T188 Arg2:E128	
*	OVERLAP E1 E2 E3 E4 E129
T189	Clinical_event 97 105	referred
E129	Clinical_event:T189 
R113	MODIFY Arg1:T8 Arg2:E129	
R114	BEFORE Arg1:E129 Arg2:E5	
*	OVERLAP E5 E6 E7 E8 E9
R115	BEFORE Arg1:E9 Arg2:E10	
*	OVERLAP E10 E11 E13 E14
R116	BEFORE Arg1:E14 Arg2:E15	
*	OVERLAP E15 E16 E17 E40 E41
R117	BEFORE Arg1:E41 Arg2:E42	
R118	BEFORE Arg1:E42 Arg2:E46	
*	OVERLAP E46 E47 E48 E50
R119	BEFORE Arg1:E50 Arg2:E51	
*	OVERLAP E51 E54 E57 E62
R120	BEFORE Arg1:E62 Arg2:E60	
*	OVERLAP E60 E64
R121	BEFORE Arg1:E64 Arg2:E65	
*	OVERLAP E65 E66 E68 E72 E74 E76
R122	BEFORE Arg1:E76 Arg2:E79	
R123	BEFORE Arg1:E79 Arg2:E81	
*	OVERLAP E81 E82
R124	BEFORE Arg1:E82 Arg2:E83	
*	OVERLAP E83 E84 E85 E86 E87 E88 E89 E97
R125	CAUSE Arg1:E97 Arg2:E96	
R126	CAUSE Arg1:E97 Arg2:E95	
R127	CAUSE Arg1:E97 Arg2:E94	
R128	CAUSE Arg1:E97 Arg2:E93	
R129	CAUSE Arg1:E97 Arg2:E92	
R130	BEFORE Arg1:E97 Arg2:E98	
*	OVERLAP E98 E99 E101 E102 E103 E104
R131	BEFORE Arg1:E104 Arg2:E106	
*	OVERLAP E106 E107 E108 E110 E109 E112 E115 E130
T190	Clinical_event 3785 3795	prescribed
E130	Clinical_event:T190 
R132	MODIFY Arg1:E130 Arg2:E117	
R133	MODIFY Arg1:E130 Arg2:E116	
R134	BEFORE Arg1:E130 Arg2:E118	
*	OVERLAP E118 E119
R135	BEFORE Arg1:E119 Arg2:E120	
*	OVERLAP E120 E121
R136	BEFORE Arg1:E121 Arg2:E122	
*	OVERLAP E122 E123 E124 E125
R137	BEFORE Arg1:E125 Arg2:E126	
*	OVERLAP E126 E127 E128
